Sihuan Pharmaceutical Holdings Group (HK:0460) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sihuan Pharmaceutical Holdings Group Ltd. has announced the purchase of 5 million shares for its 2022 Share Award Scheme, representing about 0.05% of the total shares issued, at an average price of HK$0.5450 per share. The company, known for its innovation in pharmaceuticals and medical aesthetics, aims to become a leader in China’s medical aesthetics and biopharmaceutical sectors.
For further insights into HK:0460 stock, check out TipRanks’ Stock Analysis page.
